Editas Medicine to Present at Investor Conferences in March

19:00 EST 26 Feb 2017 | Globe Newswire

CAMBRIDGE, Mass., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will participate in two upcoming investor conferences in March.  Details of the presentations are as follows:

Cowen & Company 37th Annual Healthcare Conference
Date:  Monday, March 6, 2017
Time:   2:40 p.m. ET
Location:   Boston
Barclays Global Healthcare Conference 2017
Date:  Thursday, March 16, 2017
Time:  9:30 a.m. ET
Location:  Miami

Live webcasts of the presentations will be available on the Investors & Media section of the Editas website at  Archived replays will be available for approximately 30 days following the respective presentations.

About Editas Medicine
Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes.  The company was founded by world leaders in genome editing, and its mission is to translate the promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest number of patients.

Media Contact 
Dan Budwick

Pure Communications, Inc.

(973) 271-6085

Investor Contact
Mark Mullikin
Editas Medicine, Inc.
(617) 401-9083

Primary Logo


More From BioPortfolio on "Editas Medicine to Present at Investor Conferences in March"

Quick Search


Relevant Topics

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...